An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
Summary
By Mr. Montigny, a petition (accompanied by bill, Senate, No. 652) of Mark C. Montigny, Jason M. Lewis, Jose F. Tosado, Diana DiZoglio and other members of the General Court for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices. Health Care Financing.
Bill status
passed both
4 of 5 stages cleared
Introduction
Jan 2017
Committee Review
Jan 2017
Senate Passage
Apr 2018
House Passage
Mar 2018
Governor
Introduced Jan 23, 2017
Last action May 31, 2018
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
8
Key actions
3
Committee
1
Apr 26, 2018
Upper · Passed
Senate concurred
upper
Mar 1, 2018
Lower · Passed
House concurred
lower
Jan 23, 2017
Lower · Passed
House concurred
lower
Jan 23, 2017
Committee
Referred to the committee on Health Care Financing
upper
1 primary · 27 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mark Montigny
DDemocratic
Co
Angelo M. Scaccia
DDemocratic
Co
Anne M. Gobi
DDemocratic
Co
Colleen Garry
DDemocratic
Co
Denise Provost
DDemocratic
Co
Diana DiZoglio
DDemocratic
Co
Elizabeth A. Malia
DDemocratic
Co
Harriette L. Chandler
DDemocratic
Co
James J. Dwyer
DDemocratic
Co
JM
James M. Cantwell
DDemocratic
Co
James R. Miceli
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 652
Scope: MA
Hi! I can help you understand S 652. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline